» Articles » PMID: 15001895

Tricuspid Valve Repair: Durability and Risk Factors for Failure

Overview
Date 2004 Mar 6
PMID 15001895
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To compare durability of tricuspid valve annuloplasty techniques, identify risk factors for repair failure, and characterize survival, reoperation, and functional class of surviving patients.

Methods: From 1990 to 1999, 790 patients (mean age 65 +/- 12 years, 51% New York Heart Association functional class III or IV, and mean right ventricular systolic pressure 56 +/- 18 mm Hg) underwent tricuspid valve annuloplasty for functional regurgitation using 4 techniques: Carpentier-Edwards semi-rigid ring, Cosgrove-Edwards flexible band, De Vega procedure, and customized semicircular Peri-Guard annuloplasty. Of these patients, 89% had concomitant mitral valve surgery. A total of 2245 follow-up transthoracic echocardiograms were retrieved. Tricuspid regurgitation was analyzed, and risk factors for worsening regurgitation were identified, by multivariable ordinal longitudinal methods.

Results: Tricuspid regurgitation 1 week after annuloplasty was 3+ or 4+ in 14% of patients. Regurgitation severity was stable across time with the Carpentier-Edwards ring (P =.7), increased slowly with the Cosgrove-Edwards band (P =.05), and rose more rapidly with the De Vega (P =.002) and Peri-Guard (P =.0009) procedures. Risk factors for worsening regurgitation included higher preoperative regurgitation grade, poor left ventricular function, permanent pacemaker, and repair type other than ring annuloplasty. Right ventricular systolic pressure, ring size, preoperative New York Heart Association functional class, and concomitant surgery were not risk factors. Tricuspid reoperation was rare (3% at 8 years), and hospital mortality after reoperation was 37%.

Conclusions: Tricuspid valve annuloplasty did not consistently eliminate functional regurgitation, and across time regurgitation increased importantly after Peri-Guard and De Vega annuloplasties. Therefore, these repair techniques should be abandoned, and transtricuspid pacing leads should be replaced with epicardial leads.

Citing Articles

Is concomitant tricuspid valve repair in patients undergoing robotic mitral valve repair safe and effective?.

Rowse P, AlJamal Y, Daly R, Todd A, Arghami A, Crestanello J JTCVS Open. 2025; 22():214-221.

PMID: 39780803 PMC: 11704553. DOI: 10.1016/j.xjon.2024.09.021.


Rediscovered and Unforgotten: Transcatheter Interventions for the Treatment of Severe Tricuspid Valve Regurgitation.

Rahgozar K, Bruoha S, Ho E, Goldberg Y, Chau M, Latib A US Cardiol. 2024; 15:e22.

PMID: 39720491 PMC: 11664781. DOI: 10.15420/usc.2021.06.


Preoperative Predictors of Recurrent Tricuspid Regurgitation After Annuloplasty: Insights into the Role of 3D Echocardiography.

Krivickiene A, Verikas D, Padervinskiene L, Mizariene V, Siudikas A, Jakuska P Diagnostics (Basel). 2024; 14(22).

PMID: 39594181 PMC: 11592411. DOI: 10.3390/diagnostics14222515.


Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation.

Arnold S, Spertus J, Gosch K, Dunlay S, Olds D, Jones P JAMA Cardiol. 2024; 10(2):117-125.

PMID: 39476153 PMC: 11525660. DOI: 10.1001/jamacardio.2024.4266.


National Estimates for the Percentage of All Readmissions With Demographic Features, Morbidity, Overall and Gender-Specific Mortality of Transcutaneous Versus Open Surgical Tricuspid Valve Replacement/Repair.

Khan M, Baqi A, Tahir A, Ghumman G, Ullah W, Shah J Cardiol Res. 2024; 15(4):223-232.

PMID: 39205967 PMC: 11349133. DOI: 10.14740/cr1625.